Neuromedin U and its receptors: Structure, function, and physiological roles

Pharmacological Reviews

Volumn 56, Issue 2, 2004, Pages 231-248

  Brighton, Paul J ^a   Szekeres, Philip G ^b   Willars, Gary B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARAGINE; G PROTEIN COUPLED RECEPTOR; LIGAND; NEUROMEDIN U; NEUROMEDIN U RECEPTOR 1; NEUROMEDIN U RECEPTOR 2; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; UNCLASSIFIED DRUG;

AMIDATION; AMINO ACID SEQUENCE; BLOOD FLOW; BLOOD PRESSURE; CANCER; CARBOXY TERMINAL SEQUENCE; FEEDING BEHAVIOR; GASTROINTESTINAL TRACT; HUMAN; HYPOPHYSIS; ION TRANSPORT; MOLECULAR CLONING; MOLECULAR EVOLUTION; MYOMETRIUM; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; REVIEW; SEQUENCE ANALYSIS; SMOOTH MUSCLE CONTRACTION; STOMACH ACID SECRETION; STRESS; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; RECEPTORS, NEUROTRANSMITTER;

EID: 2642553111     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.56.2.3     Document Type: Review

References (125)

1. Abiko T and Takamura Y (2002) Synthesis of two neuromedin U (NmU) analogues and their comparative effect of reducing food intake in rats. Prep Biochem Biotech 32:79-86.
2. Abiko T and Takamura Y (2003) Syntheses of two neuromedin U (NmU) analogues and their comparative reducing food intake effect in rats. Amino Acids 25:107-110.
3. q/11 and Gi/0 activation in CHO-cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype. Brit J Pharmacol 132:950-958.
4. Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, Gallagher GT, Varvares M, Cohen D, Kim D, et al. (2001) Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20:6196-6204.
5. Augood SJ, Keast JR, and Emson PC (1988) Distribution and characterization of neuromedin-U-like immunoreactivity in rat-brain and intestine and in guinea-pig intestine. Regul Peptides 20:281-292.
6. Austin C, Lo G, Nandha KA, Meleagros L, and Bloom SR (1995) Cloning and characterization of the cDNA-encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal-tract. J Mol Endocrinol 14: 157-169.
7. Austin C, Oka M, Nandha KA, Legon S, Khandannia N, Lo G, and Bloom SR (1994) Distribution and developmental pattern of neuromedin-U expression in the rat gastrointestinal-tract. J Mol Endocrinol 12:257-263.
8. Ballesta J, Carlei F, Bishop AE, Steel JH, Gibson SJ, Fahey M, Hennessey R, Domin J, Bloom SR, and Polak JM (1988) Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal-tract and brain of the rat. Neuroscience 25:797-816.
9. Barak LS, Oakley RH, Laporte SA, and Caron MG (2001) Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci USA 98:93-98.
10. Benito-Orfila MA, Domin J, Nandha KA, and Bloom SR (1991) The motor effect of neuromedin-U on rat stomach in vitro. Eur J Pharmacol 193:329-333.
11. Bishop AE, Ballesta J, Carlei F, Steel JH, Gibson SJ, Fahey M, Hennessey R, Domin J, Bloom SR, and Polak JM (1988) The distribution and development of a new brain and gut peptide, neuromedin-U. J Pathol 154:A99-A100.
12. Blom N, Gammeltoft S, and Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:1351-1362.
13. Bockman CS, Abel PW, Hicks JW, and Conlon JM (1989) Evidence that neuromedin-U may regulate gut motility in reptiles but not in mammals. Eur J Pharmacol 171:255-257.
14. Bodanszky MM, Klausner YS, and Siad SI (1973) Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide. Proc Natl Acad Sci USA 70:382-384.
15. Boel E, Schwartz TW, Norris KE, and Fiil NP (1984) A cDNA-encoding a small common precursor for human pancreatic-polypeptide and pancreatic icosapeptide. EMBO (Eur Mol Biol Organ) J 3:909-912.
16. Bradbury AF and Smyth DG (1987) Biosynthesis of the C-terminal amide in peptide-hormones. Bioscience Rep 7:907-916.
17. Brighton PJ, Szekeres PG, Aiyar N, and Willars GB (2003) Characterisation of signalling by recombinant human neuromedin-U receptors. Br J Pharmacol 140: 75P
18. Brown DR and Quito FL (1988) Neuromedin-U octapeptide alters ion-transport in porcine jejunum. Eur J Pharmacol 155:159-162.
19. Cao CQ, Yu XH, Dray A, Filosa A, and Perkins MN (2003) A pro-nociceptive role of neuromedin U in adult mice. Pain 104:609-616.
20. Chu CP, Jin QH, Kunitake T, Kato K, Nabekura T, Nakazato M, Kanagawa K, and Kannan H (2002) Cardiovascular actions of central neuromedin U in conscious rats. Regul Peptides 105:29-34.
21. Conlon JM, Domin J, Thim L, Dimarzo V, Morris HR, and Bloom SR (1988) Primary structure of neuromedin-U from the rat. J Neurochem 51:988-991.
22. Considine RV and Caro JF (1997) Leptin and the regulation of body weight. Int J Biochem Cell B 29:1255-1272.
23. Domin J, Almadani AM, Desperbasques M, Bishop AE, Polak JM, and Bloom SR (1990) Neuromedin U-like immunoreactivity in the thyroid-gland of the rat. Cell Tissue Res 260:131-135.
24. Domin J, Benito-Orfila MA, Nandha KA, Aitken A, and Bloom SR (1992) The purification and sequence-analysis of an avian neuromedin-U. Regul Peptides 41:1-8.
25. Domin J, Conlon JM, Dimarzo V, Thim L, Morris HR, and Bloom SR (1988) The purification and sequence-analysis of rat neuromedin-U. Regul Peptides 22:400.
26. Domin J, Ghatei MA, Chohan P, and Bloom SR (1986) Characterization of neuromedin-U like immunoreactivity in rat, porcine guinea-pig and human-tissue extracts using a specific radioimmunoassay. Biochem Biophys Res Commun 140:1127-1134.
27. Domin J, Ghatei MA, Chohan P, and Bloom SR (1987) Neuromedin U - A study of its distribution in the rat. Peptides 8:779-784.
28. Domin J, Yiangou Y, Spokes R, Aitken A, Parmar K, Chrysanthou BJ, and Bloom SR (1989) The purification and characterization of amphibian neuramedin-U. Regul Peptides 26:67.
29. Duggan JP and Booth DA (1980) Obesity, overeating and rapid gastric emptying in rats with ventromedial hypothalamic lesions. Science (Wash DC) 231:609-611.
30. Eipper BA and Mains RE (1988) Peptide alpha-amidation. Annu Rev Physiol 50: 333-344.
31. Escher E, Couture R, Poulos C, Pinas N, Mizrahi J, Theodoropoulos D, and Regoli D (1982) Structure activity studies on the C-terminal amide of substance-P. J Med Chem 25:1317-1321.
32. Fisher JM and Scheller RH (1988) Prohormone processing and the secretory pathway. J Biol Chem 263:16515-16518.
33. Friedman JM and Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature (Lond) 395:763-770.
34. Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Habata Y, Hinuma S, Onda H, Nishimura O, and Fujino M (2000) Identification of neuromedin U as the cognate ligand of the orphan G-protein-coupled receptor FM-3. J Biol Chem 275:21068-21074.
35. Funes S, Hedrick JA, Yang SJ, Shan LX, Bayne M, Monsma FJ, and Gustafson EL (2002) Cloning and characterization of murine neuromedin U receptors. Peptides 23:1607-1615.
36. Furness JB, Pompolo S, Murphy R, and Giraud A (1989) Projections of neurons with neuromedin U-like immunoreactivity in the small-intestine of the guinea-pig. Cell Tissue Res 257:415-422.
37. Gardiner SM, Compton AM, Bennett T, Domin J, and Bloom SR (1990) Regional hemodynamic-effects of neuromedin-U in conscious rats. Am J Physiol 258:R32-R38.
38. Graham ES, Turnbull Y, Fotheringham P, Nilaweera K, Mercer JG, Morgan PJ, and Barrett P (2003) Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status. J Neurochem 87:1165-1175.
39. Gupta R and Brunak S (2002) Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput 310-322.
40. Hanada R, Nakazato M, Murakami N, Sakihara S, Yoshimatsu H, Toshinai K, Hanada T, Suda T, Kangawa K, Matsukura S, and Sakata T (2001) A role for neuromedin U in stress response. Biochem Biophys Res Commun 289:225-228.
41. Hanada T, Date Y, Shimbara T, Sakihara S, Murakami N, Hayashi Y, Kanai Y, Suda T, Kangawa K, and Nakazato M (2003) Central actions of neuromedin U via corticotrophin-releasing hormone. Biochem Biophys Res Commun 311:954-958.
42. Hashimoto T, Kurosawa K, and Sakura N (1995) Structure-activity-relationships of neuromedin-U. ii. Highly potent analogs substituted or modified at the N-terminus of neuromedin-U-8. Chem Pharm Bull 43:1154-1157.
43. Hashimoto T, Masui H, Uchida Y, Sakura N, and Okimura K (1991) Agonistic and antagonistic activities of neuromedin-U-8 analogs substituted with glycine or D-amino acid on contractile activity of chicken crop smooth-muscle preparations. Chem Pharm Bull 39:2319-2322.
44. Hedrick JA, Morse K, Shan LX, Qiao XD, Pang L, Wang S, Laz T, Gustafson EL, Bayne M, and Monsma FJ (2000) Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol Pharmacol 58:870-875.
45. Holmgren S and Jensen J (2001) Evolution of vertebrate neuropeptides. Brain Res Bull 55:723-735.
46. Honzawa M, Sudoh T, Minamino N, Kangawa K, and Matsuo H (1990) Neuromedin-U-like immunoreactivity in rat intestine - regional distribution and immunohistochemical study. Neuropeptides 15:1-9.
47. Honzawa M, Sudoh T, Minamino N, Tohyama M, and Matsuo H (1987) Topographic localization of neuromedin U-like structures in the rat-brain: an immunohistochemical study. Neuroscience 23:1103-1122.
48. Hosoya M, Moriya T, Kawamata Y, Ohkubo S, Fujii R, Matsui H, Shintani Y, Fukusumi S, Habata Y, Hinuma S, et al. (2000) Identification and functional characterization of a novel subtype of neuromedin U receptor. J Biol Chem 275: 29528-29532.
49. Howard AD, Wang RP, Pong SS, Mellin TN, Strack A, Guan XM, Zeng ZZ, Williams DL, Feighner SD, Nunes CN, et al. (2000) Identification of receptors for neuromedin U and its role in feeding. Nature (Lond) 406:70-74.
50. Inui A (1999) Feeding and body-weight regulation by hypothalamic neuropeptides - mediation of the actions of leptin. Trends Neurosci 22:62-67.
51. Ivanov TR, Lawrence CB, Stanley PJ, and Luckman SM (2002) Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143:3813-3821.
52. Kage R, O'Harte F, Thim L, and Conlon JM (1991) Rabbit neuromedin U-25: lack of conservation of a post-translational processing site. Regul Peptides 33:191-198.
53. Kangawa K, Minamino N, Fukuda A, and Matsuo H (1983) Neuromedin-K - a novel mammalian tachykinin identified in porcine spinal-cord. Biochem Biophys Res Commun 114:533-540.
54. Kelly KA (1980) Gastric emptying of liquids and solids: roles of proximal and distal stomach. Am J Physiol 239:G71-G76.
55. Kennelly PJ and Krebs EG (1991) Consensus sequences as substrate-specificity determinants for protein-kinases and protein phosphatases. J Biol Chem 266: 15555-15558.
56. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DGA, Small CJ, Edwards CMB, Heath MM, Stanley SA, Seal LJ, et al. (2000) Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone. Diabetes 49:177-182.
57. Kojima M, Haruno R, Nakazato M, Date Y, Murakami N, Hanada R, Matsuo H, and Kangawa K (2000) Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem Biophys Res Commun 276:435-438.
58. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, and Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (Lond) 402:656-660.
59. Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292.
60. Kozak M (1991a) Structural features in eukaryotic messenger-RNAs that modulate the initiation of translation. J Biol Chem 266:19867-19870.
61. Kozak M (1991b) An analysis of vertebrate messenger-RNA sequences: intimations of translational control. J Cell Biol 115:887-903.
62. Kurosawa K, Sakura N, and Hashimoto T (1996) Structure-activity relationships of neuromedin U. iii. Contribution of two phenylalanine residues in dog neuromedin U-8 to the contractile activity. Chem Pharm Bull 44:1880-1884.
63. Lindström E, Björkqvist M, Boketoft Å, Chen D, Zhao CM, Kimura K, and Håkanson R (1997) Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells. Regul Peptides 71:73-86.
64. Lo G, Legon S, Austin C, Wallis S, Wang ZI, and Bloom SR (1992) Characterization of complementary-DNA encoding the rat neuromedin-U precursor. Mol Endocrinol 6:1538-1544.
65. Luttrell LM, Daaka Y, and Lefkowitz RJ (1999) Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11:177-183.
66. Maggi CA, Patacchini R, Giuliani S, Turini D, Barbanti G, Rovero P, and Meli A (1990) Motor response of the human isolated small-intestine and urinary-bladder to porcine neuromedin U-8. Brit J Pharmacol 99:186-188.
67. Malendowicz KA, Nussdorfer GG, Nowak KW, and Mazzocchi G (1993) Effects of neuromedin U-8 on the rat pituitary-adrenocortical axis. In Vivo 7:419-422.
68. Malendowicz LK, Andreis PG, Markowska A, Nowak M, Warchol JB, Neri G, and Nussdorfer GG (1994a) Effects of neuromedin U-8 on the secretory activity of the rat adrenal-cortex: evidence for an indirect action requiring the presence of the zona medullaris. Res Exp Med 194:69-79.
69. Malendowicz LK, Nussdorfer GG, Markowska A, Tortorella C, Nowak M, and Warchol JB (1994b) Effects of neuromedin-U (NmU)-8 on the rat hypothalamo-pituitary-adrenal axis: evidence of a direct effect of NmU-8 on the adrenal-gland. Neuropeptides 26:47-53.
70. Minamino N, Kangawa K, Fukuda A, and Matsuo H (1984a) Neuromedin-L - a novel mammalian tachykinin identified in porcine spinal-cord. Neuropeptides 4:157-166.
71. Minamino N, Kangawa K, Honzawa M, and Matsuo H (1988) Isolation and structural determination of rat neuromedin-U. Biochem Biophys Res Commun 156: 355-360.
72. Minamino N, Kangawa K, and Matsuo H (1984b) Neuromedin-C - a bombesin-like peptide identified in porcine spinal-cord. Biochem Biophys Res Commun 119:14-20.
73. Minamino N, Kangawa K, and Matsuo H (1984c) Neuromedin-N - a novel neurotensin-like peptide identified in porcine spinal-cord. Biochem Biophys Res Commun 122:542-549.
74. Minamino N, Kangawa K, and Matsuo H (1985a) Neuromedin-U-8 sed and neuromedin-U-25 - novel uterus stimulating and hypertensive peptides identified in porcine spinal-cord. Biochem Biophys Res Commun 130:1078-1085.
75. Minamino N, Sudoh T, Kangawa K, and Matsuo H (1985b) Neuromedins-novel smooth-muscle stimulating peptides identified in porcine spinal-cord. Peptides 6:245-248.
76. Mondal MS, Date Y, Murakami N, Toshinai K, Shimbara T, Kangawa K, and Nakazato M (2003) Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system. Am J Physiol 284:G963-G969.
77. Morgan PJ and Williams LM (1996) The pars tuberalis of the pituitary: a gateway for neuroendocrine output. Rev Reprod 1:153-161.
78. Morley JE and Levine AS (1982) Corticotropin releasing-factor, grooming and ingestive behavior. Life Sci 31:1459-1464.
79. Munck A and Naray-Fejes-Toth A (1994) Glucocorticoids and stress - permissive and suppressive actions. Ann NY Acad Sci 746:115-130.
80. Murphy R, Turner CA, Furness JB, Parker L, and Giraud A (1990) Isolation and microsequence analysis of a novel form of neuromedin-U from guinea-pig small-intestine. Peptides 11:613-617.
81. Mutt V and Said SI (1974) Structure of porcine vasoactive intestinal octacosapeptide. The amino acid sequence. Use of kallikrein in its determination. Eur J Biochem 42:581-589.
82. Nakazato M, Hanada R, Murakami N, Date Y, Mondal MS, Kojima M, Yoshimatsu H, Kangawa K, and Matsukura S (2000) Central effects of neuromedin U in the regulation of energy homeostasis. Biochem Biophys Res Commun 277:191-194.
83. Nandha KA, Benito-Orfila MA, Smith DM, and Bloom SR (1993) Characterization of the rat uterine neuromedin-U receptor. Endocrinology 133:482-486.
84. Nicholas KB, Nicholas HBJ, and Deerfield IIDW (1997) GeneDoc: analysis and visualization of genetic variation. EMBnet news 4:14.
85. Niimi M, Murao K, and Taminato T (2001) Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem. Endocrine 16:201-206.
86. Norlen P, Bernsand M, Konagaya T, and Hakanson R (2001) ECL-cell histamine mobilization in conscious rats: effects of locally applied regulatory peptides, candidate neurotransmitters and inflammatory mediators. Brit J Pharmacol 134: 1767-1777.
87. O'Harte F, Bockman CS, Abel PW, and Conlon JM (1991a) Isolation, structural characterization and pharmacological activity of dog neuromedin-U. Peptides 12: 11-15.
88. O'Harte F, Bockman CS, Zeng WY, Abel PW, Harvey S, and Conlon JM (1991b) Primary structure and pharmacological activity of a nonapeptide related to neuromedin-U isolated from chicken intestine. Peptides 12:809-812.
89. Okimura K, Sakura N, Ohta S, Kurosawa K, and Hashimoto T (1992) Contractile activity of porcine neuromedin U-25 and various neuromedin U-related peptide-fragments on isolated chicken crop smooth-muscle. Chem Pharm Bull 40:1500-1503.
90. Olson BR, Drutarosky MD, Chow MS, Hruby VJ, Stricker EM, and Verbalis JG (1991a) Oxytocin and an oxytocin agonist administered centrally decrease food-intake in rats. Peptides 12:113-118.
91. Olson BR, Drutarosky MD, Stricker EM, and Verbalis JG (1991b) Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats - evidence for central oxytocin inhibition of food-intake. Endocrinology 129:785-791.
92. Ozaki Y, Onaka T, Nakazato M, Saito J, Kanemoto K, Matsumoto T, and Ueta Y (2002) Centrally administered neuromedin U activates neurosecretion and induction of C-Fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology 143:4320-4329.
93. Pearson RB and Kemp BE (1991) Protein-kinase phosphorylation site sequences and consensus specificity motifs - tabulations. Method Enzymol 200:62-81.
94. Perlman JH, Wang W, Nussenzveig DR, and Gershengorn MC (1995) A disulfide bond between conserved extracellular cysteines in the thyrotropin-releasing-hormone receptor is critical for binding. J Biol Chem 270:24682-24685.
95. Pitcher JA, Freedman NJ, and Lefkowitz RJ (1998) G protein-coupled receptor kinases. Annu Rev Biochem 67:653-692.
96. H channel activity. J Neurophysiol 90:843-850.
97. Quan H, Funabashi T, Furuta M, and Kimura F (2003) Effects of neuromedin U on the pulsatile LH secretion in ovariectomized rats in association with feeding conditions. Biochem Biophys Res Commun 311:721-727.
98. Raddatz R, Wilson AE, Artymyshyn R, Bonini JA, Borowsky B, Boteju LW, Zhou SQ, Kouranova EV, Nagorny R, Guevarra MS, et al. (2000) Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J Biol Chem 275:32452-32459.
99. Rhee MH, Nevo I, Levy R, and Vogel Z (2000) Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor. FEBS Lett 466:300-304.
100. Rinaman L, Baker EA, Hoffman GE, Stricker EM, and Verbalis JG (1998) Medullary C-Fos activation in rats after ingestion of a satiating meal. Am J Physiol 44:R262-R268.
101. Sakura N, Kurosawa K, and Hashimoto T (1995) Structure-activity-relationships of neuromedin-U. i. Contractile activity of dog neuromedin-U-related peptides on isolated chicken crop smooth-muscle. Chem Pharm Bull 43:1148-1153.
102. Sakura N, Ohta S, Uchida Y, Kurosawa K, Okimura K, and Hashimoto T (1991) Structure-activity-relationships of rat neuromedin-U for smooth-muscle contraction. Chem Pharm Bull 39:2016-2020.
103. Sakura N, Kurosawa K, and Hashimoto T (2000) Structure-activity relationships of neuromedin U. iv. Absolute requirement of the arginine residue at position 7 of dog neuremedin U-8 for contractile activity. Chem Pharm Bull 48:1166-1170.
104. Salmon AL, Johnsen AH, Bienert M, McMurray G, Nandha KA, Bloom SR, and Shaw C (2000) Isolation, structural characterization and bioactivity of a novel neuromedin U analog from the defensive skin secretion of the Australasian tree frog, Litoria Caerulea. J Biol Chem 275:4549-4554.
105. Sapolsky RM, Romero LM, and Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr Rev 21:55-89.
106. 1 muscarinic acetylcholine-receptor - role of conserved cysteines in receptor function. J Biol Chem 267:11439-11448.
107. 1b-adrenergic receptor: Effects on receptor isomerization and activation. Mol Pharmacol 57:219-231.
108. Shan LX, Qiao XD, Crona JH, Behan J, Wang S, Laz T, Bayne M, Gustafson EL, Monsma FJ, and Hedrick JA (2000) Identification of a novel neuromedin U receptor subtype expressed in the central nervous system. J Biol Chem 275:39482-39486.
109. Steel JH, Vannoorden S, Ballesta J, Gibson SJ, Ghatei MA, Burrin J, Leonhardt U, Domin J, Bloom SR, and Polak JM (1988) Localization of 7B2, neuremedin-B, and neuromedin-U in specific cell-types of rat, mouse, and human pituitary, in rat hypothalamus and in 30 human pituitary and extrapituitary tumors. Endocrinology 122:270-282.
110. Strader CD, Fong TM, Tota MR, Underwood D, and Dixon RAF (1994) Structure and function of G-protein-coupled receptors. Annu Rev Biochem 63:101-132.
111. Sumi S, Inoue K, Kogire M, Doi R, Takaori K, Suzuki T, Yajima H, and Tobe T (1987) Effect of synthetic neuromedin U-8 and U-25, novel peptides identified in porcine spinal-cord, on splanchnic circulation in dogs. Life Sci 41:1585-1590.
112. Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, Smith A, Rennie GI, Murdock PR, Fitzgerald LR, Wu HL, et al. (2000) Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J Biol Chem 275:20247-20250.
113. Tache Y, Garrick T, and Raybould H (1990) Central nervous-system action of peptides to influence gastrointestinal motor function, Gastroenterology 98:517-528.
114. Tache Y and Yang H (1990) Brain regulation of gastric-acid secretion by peptides - sites and mechanisms of action. Ann NY Acad Sci 597:128-145.
115. Tan CP, McKee KK, Liu QY, Palyha OC, Feighner SD, Hreniuk DL, Smith RG, and Howard AD (1998) Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. Genomics 52:223-229.
116. Tatemoto KMV (1978) Chem determination of polypeptide hormones. Proc Natl Acad Sci USA 75:4115-4119.
117. Timmermans JP, Scheuermann DW, Stach W, Adriaensen D, Degroodtlasseel MHA, and Polak JM (1989) Neuromedin U-immunoreactivity in the nervous-system of the small-intestine of the pig and its co-existence with substance-P and CGRP. Cell Tissue Res 258:331-337.
118. Timmermans JP, Scheuermann DW, Stach W, Adriaensen D, and Degroodtlasseel MHA (1990) Distinct distribution of CGRP-containing, enkephalin-containing, galanin-containing, neuromedin U-containing, neuropeptide Y-containing, somatostatin-containing, substance P-containing, VIP-containing and serotonin-containing neurons in the 2 submucosal ganglionic neural networks of the porcine small-intestine. Cell Tissue Res 260:367-379.
119. Tusnády GE and Simon I (1998) Principles governing amino acid composition of integral membrane proteins: Application to topology prediction. J Mol Biol 283: 489-506.
120. Tusnády GE and Simon I (2001) The HMMTOP transmembrane topology prediction server. Bioinformatics 17:849-850.
121. Westfall TD, McCafferty GP, Pullen M, Gruver S, Sulpizio AC, Aiyar VN, Disa J, Contino LC, Mannan IJ, and Hieble JP (2001) Characterisation of neuromedin U effects in canine smooth-muscle. J Pharmacol Exp Ther 301:987-992.
122. Wilbanks AM, Laporte SA, Bohn LM, Barak LS, and Caron MG (2002) Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors. Biochemistry 41:11981-11989.
123. Wren AM, Small CJ, Abbott CR, Jethwa PH, Kennedy AR, Murphy KG, Stanley SA, Zollner AN, Ghatei MA, and Bloom SR (2002) Hypothalamic actions of neuromedin U. Endocrinology 143:4227-4234.
124. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, and Sidransky D (2002) Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2:485-495.
125. Yu XH, Cao CQ, Mennicken F, Puma C, Dray A, O'Donnell D, Ahmad S, and Perkins M (2003) Pro-nociceptive effects of neuromedin U in rat. Neuroscience 120:467-474.